Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-23-000534

Chief Commercial Officer sold 6,568 shares at $4.18 ($27,440)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ludwig Jeffrey Jerome Chief Commercial Officer 2023-01-03 Sale −6,568 $4.18 $27,440 58,057 D
Open-market sales · 6,568 sh · avg $4.18 · $27,440
Loading xslF345X03/rdgdoc.xml…